ARTHROPLASTY
COA/ICORS2019: No difference between dexmedetomidine and epinephrine for block extension in TKA
70 patients scheduled for total knee arthroplasty and were managed with multimodal analgesia consisting of a continuous adductor canal block, single shot lateral femoral cutaneous nerve block, and posterior infiltration were randomized to either additional dexmedetomidine or epinephrine to a solution of ropivacaine, morphine, and ketorolac. The purpose of this study was to determine if there was a significant difference in time to first rescue analgesia request between groups. Results demonstrated no significant difference between groups in time to first rescue analgesia request, or in mean pain scores or opioid consumption over the first 24 hours after surgery.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
